Zobrazeno 1 - 10
of 26
pro vyhledávání: '"John A, Cuenca"'
Autor:
John A. Cuenca, MD, Joseph L. Nates, MD, MBA, MCCM, Andres Laserna, MD, Alba J. Heatter, MD, Nirmala Manjappachar, MD, Peyton Martin, BS, Maria P. Reyes, MD, Mike Hernandez, MS, Jacob Hall, PharmD, Claudia M. Ramirez, MD, Diego H. de Villalobos, MD
Publikováno v:
Critical Care Explorations, Vol 6, Iss 4, p e1070 (2024)
A prospective cohort study was conducted to evaluate the 1-year survival of cancer patients with sepsis and vasopressor requirements. Eligible patients were admitted a Comprehensive Cancer Center’s ICU and were compared based on their admission lac
Externí odkaz:
https://doaj.org/article/7b065e5d973b4916978f9b71f9c6948d
Autor:
John A. Cuenca, Ankit Hanmandlu, Robert Wegner, Joshua Botdorf, Sudhakar Tummala, Cezar A. Iliescu, Joseph L. Nates, Dereddi R. Reddy
Publikováno v:
BMC Anesthesiology, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Checkpoint inhibitor-induced overlap syndrome ([OS] myocarditis, and myositis with or without myasthenia gravis) is rare but life-threatening. Cases presentation Here we present a case series of four cancer patients that developed
Externí odkaz:
https://doaj.org/article/5259125ac93842c3a06aeffebf8d1451
Autor:
John Alberto Cuenca Sedamanos, José Nicasio Quevedo Guerrero, Ivana Gabriela Tuz Guncay, Julio Enrique Chabla Carillo
Publikováno v:
Ciencia y Agricultura, Vol 19, Iss 3 (2022)
El uso de Trichoderma spp en la agricultura orgánica es importante debido a su amplio modo de acción que incluye: la segregación de metabolitos secundarios que inducen la producción de fitoalexinas en las plantas y su capacidad antagonista, adem
Externí odkaz:
https://doaj.org/article/500dc5798b524f9fb9340e7becc8a003
Autor:
Lama H. Nazer, PharmD, FCCM, Maria A. Lopez-Olivo, MD, PhD, Anne Rain Brown, PharmD, FCCM, John A. Cuenca, MD, Michael Sirimaturos, PharmD, FCCM, Khader Habash, PharmD, Nada AlQadheeb, PharmD, Heather May, PharmD, Victoria Milano, PharmD, Amy Taylor, Joseph L. Nates, MD, MBA, MCCM
Publikováno v:
Critical Care Explorations, Vol 4, Iss 9, p e0757 (2022)
OBJECTIVES:. The reported mortality rates of cancer patients admitted to ICUs vary widely. In addition, there are no studies that examined the outcomes of critically ill cancer patients based on the geographical regions. Therefore, we aimed to evalua
Externí odkaz:
https://doaj.org/article/cb7f491e78da44fdbeb7d4f092b6bdeb
Autor:
Diego de Villalobos, Andres Laserna, Cosmo Fowler, John A. Cuenca, Peyton Martin, Michele Guindani, Wenli Dong, Howard B. Gutstein, Kristen J. Price, Joseph L. Nates
Publikováno v:
Anaesthesiology Intensive Therapy, Vol 53, Iss 3, Pp 223-231 (2021)
Externí odkaz:
https://doaj.org/article/37359329e30345b4a0fff0d228ab020e
Publikováno v:
Gaceta Mexicana de Oncología, Vol 21, Iss 1 (2022)
La terapia de células T con receptores de antígeno quimérico (CAR-T, en inglés) es una de las más avanzadas formas de inmunoterapia. Se basa en la modificación genética de linfocitos T por medio de un retrovirus que funciona como vector. El ma
Externí odkaz:
https://doaj.org/article/32283fe724574d35b518c89ff687d28e
Autor:
Edison Fabricio Vera-Cruz, José Nicasio Quevedo-Guerrero, Ivanna Gabriela Tuz-Guncay, Julio Enrique Chabla-Carillo, John Alberto Cuenca-Sedamanos
Publikováno v:
Ciencia y Agricultura, Vol 20, Iss 1, Pp 14691-14691 (2023)
Tomando en cuenta, por una parte, que el cultivo de maní en el Ecuador ha perdido interés agrícola debido a su susceptibilidad ante enfermedades fúngicas, y por otra, que la aplicación de microorganismos del género Trichoderma controla eficient
Externí odkaz:
https://doaj.org/article/97269dadbf6c407c970f2697c09f31ff
Autor:
Dereddi Raja Reddy, John A. Cuenca, Joshua Botdorf, Mayoora Muthu, Ankit Hanmandlu, Robert Wegner, John Crommett, Cristina Gutierrez, Nisha Rathi, Bilja Sajith, Mark Knafl, Hussein A. Abbas, Scott E. Woodman, Joseph L. Nates, Ashley Aaroe, Thomas A. Aloia, Lee Andrews, Kiran K. Badami, Janna A. Baganz, Pratibha Bajwa, Lori R. Baker, Gregory R. Barbosa, Hannah C. Beird, Matt Bourgeois, Kristy Brock, Elizabeth M. Burton, Juan Cata, Caroline Chung, Michael Cutherell, Pierre B. Cyr, Bouthaina Dabaja, Hiba Dagher, Kevin M. Daniels, Mary Domask, Giulio Draetta, Sarah Fisher, Katy Elizabeth French, Andrew Futreal, Maria Gaeta, Christopher Gibbons, Myrna Godoy, Drew Goldstein, Jillian Gunther, Cristhiam Hernandez, Kate Hutcheson, David Jaffray, Jeff Jin, Teny Matthew John, Trey Kell, Anai Kothari, Rayson C. Kwan, J. Jack Lee, Yue Liao, Jennifer Litton, Alex Liu, Kevin W. McEnery, Mary McGuire, Tego Musunuru, Craig S. Owen, Priyadharshini Padmakumar, Melody Page, Nicholas Palaskas, Jay J. Patel, Sabitha Prabhakaran, Vinod Ravi, Ludivine Russell, Paul A. Scheet, Stephanie Schmidt, Kenna R. Shaw, Sanjay Shete, Daniel P. Shoenthal, Lessley J. Stoltenberg, Ishwaria Subbiah, Chuck Suitor, Hussein Tawbi, Phillip Thompson, Anastasia Turin, Samir Unni, Benju Vicknamparampil, Max C. Weber, John Weinstein, Zoe Williams, Mark C. Wozny, Carol Wu, Jia Wu, James C. Yao, Chingyi Young, Emily Yu, Steven Zatorski
Publikováno v:
Mayo Clinic Proceedings. 98:451-457
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0e4285ed56e25e2fcce40cf942510c3
https://doi.org/10.1016/j.mayocp.2022.12.008
https://doi.org/10.1016/j.mayocp.2022.12.008
Publikováno v:
Case Reports in Critical Care, Vol 2020 (2020)
Background. Pembrolizumab is a checkpoint inhibitor that targets the programmed cell death-1 receptor (PD-1) and has shown to be effective against several malignancies, including lung cancer. However, life-threatening immune-related adverse events ca
Externí odkaz:
https://doaj.org/article/839a658d12af412ea86c5e0819bf6087
Autor:
John A. Cuenca, Nirmala K. Manjappachar, Claudia M. Ramírez, Mike Hernandez, Peyton Martin, Cristina Gutierrez, Nisha Rathi, Charles L. Sprung, Kristen J. Price, Joseph L. Nates
Publikováno v:
Chest. 162:1063-1073
Data assessing outcomes of patients with solid tumors demonstrating septic shock using the Third International Consensus Definitions for Sepsis and Septic Shock are scarce.What are the independent predictors of 28-day mortality in critically ill adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d998af5617f4da6e6e79e3865302cc9
https://doi.org/10.1016/j.chest.2022.05.017
https://doi.org/10.1016/j.chest.2022.05.017